文献速递乳腺MR

致密型乳腺补充筛查的简化乳腺MRI:基线检查与后续轮次检查的比较

Abbreviated Breast MRI for Supplemental Screening in Patients With Dense Breasts: Comparison of Baseline Versus Subsequent-Round Examinations.
PubMed 文献 · AJR Am J Roentgenol · 2024-05-22

本回顾性研究纳入2007名致密型乳腺且其他方面为平均风险的女性,共2585次简化乳腺MRI补充筛查(2007次基线、578次后续轮次)。后续轮次的异常解读率低于基线(7.8% vs 17.4%,p<.001),癌检出率分别为每1000次检查18.9例与12.1例(p=.37);所有检出的45例癌均为0期或1期。

要点

  • 致密型乳腺简化乳腺MRI补充筛查中,后续轮次异常解读率7.8%(45/578)低于基线17.4%(349/2007),p<.001。
  • 基线癌检出率每1000次检查18.9例(38/2007),后续轮次每1000次检查12.1例(7/578),p=.37。
  • 后续轮次检出的7例癌均为淋巴结阴性早期癌,其中6例浸润性成分均≤1.2 cm。

核心结论

  • 致密型乳腺简化乳腺MRI后续轮次筛查的异常解读率低于基线检查,同时维持较高的癌检出率;后续轮次检出的癌均为早期淋巴结阴性癌。

研究设计与样本

  • 回顾性研究,纳入2007名致密型乳腺且其他方面为平均风险的女性,2016年12月20日至2023年5月10日期间行简化乳腺MRI补充筛查,共2585次检查(2007次基线、578次后续轮次),从电子病历提取临床解读和推荐活检结果。

诊断标准与关键数值

  • 基线检查BI-RADS 1或2类1658次(82.6%)、3类171次(8.5%)、4或5类178次(8.9%);后续轮次分别为533次(92.2%)、20次(3.5%)、25次(4.3%),p<.001。基线异常解读率17.4%(349/2007)vs后续轮次7.8%(45/578),p<.001;基线PPV2 21.3%(38/178)、PPV3 26.6%(38/143)、癌检出率每1000次检查18.9例(38/2007);后续轮次PPV2 28.0%(7/25)(p=.45)、PPV3 29.2%(7/24)(p=.81)、癌检出率每1000次检查12.1例(7/578)(p=.37)。

临床应用与阅片要点

  • 作者认为研究结果支持对致密型乳腺人群进行序贯简化乳腺MRI补充筛查;作者指出需进一步研究以优化筛查间隔。

局限性

  • 原文指出需进一步研究以优化筛查间隔。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. Abbreviated breast MRI (AB-MRI) achieves a higher cancer detection rate (CDR) than digital breast tomosynthesis when applied for baseline (i.e., first-round) supplemental screening of individuals with dense breasts. Limited literature has evaluated subsequent (i.e., sequential) AB-MRI screening rounds. OBJECTIVE. This study aimed to compare outcomes between baseline and subsequent rounds of screening AB-MRI in individuals with dense breasts who otherwise had an average risk for breast cancer. METHODS. This retrospective study included patients with dense breasts who otherwise had an average risk for breast cancer and underwent AB-MRI for supplemental screening between December 20, 2016, and May 10, 2023. The clinical interpretations and results of recommended biopsies for AB-MRI examinations were extracted from the EMR. Baseline and subsequent-round AB-MRI examinations were compared. RESULTS. The final sample included 2585 AB-MRI examinations (2007 baseline and 578 subsequent-round examinations) performed for supplemental screening of 2007 women (mean age, 57.1 years old) with dense breasts. Of 2007 baseline examinations, 1658 (82.6%) were assessed as BI-RADS category 1 or 2, 171 (8.5%) as BI-RADS category 3, and 178 (8.9%) as BI-RADS category 4 or 5. Of 578 subsequent-round examinations, 533 (92.2%) were assessed as BI-RADS category 1 or 2, 20 (3.5%) as BI-RADS category 3, and 25 (4.3%) as BI-RADS category 4 or 5 (p < .001). The abnormal interpretation rate (AIR) was 17.4% (349/2007) for baseline examinations versus 7.8% (45/578) for subsequent-round examinations (p < .001). For baseline examinations, PPV2 was 21.3% (38/178), PPV3 was 26.6% (38/143), and the CDR was 18.9 cancers per 1000 examinations (38/2007). For subsequent-round examinations, PPV2 was 28.0% (7/25) (p = .45), PPV3 was 29.2% (7/24) (p = .81), and the CDR was 12.1 cancers per 1000 examinations (7/578) (p = .37). All 45 cancers diagnosed by baseline or subsequent-round AB-MRI were stage 0 or 1. Seven cancers diagnosed by subsequent-round AB-MRI had a mean interval of 872 ± 373 (SD) days since prior AB-MRI and node-negative status at surgical axillary evaluation; six had an invasive component, all measuring 1.2 cm or less. CONCLUSION. Subsequent rounds of AB-MRI screening of individuals with dense breasts had lower AIR than baseline examinations while maintaining a high CDR. All cancers detected by subsequent-round examinations were early-stage node-negative cancers. CLINICAL IMPACT. The findings support sequential AB-MRI for supplemental screening in individuals with dense breasts. Further investigations are warranted to optimize the screening interval.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Edmonds CE, Weinstein SP, McDonald ES, et al. Abbreviated Breast MRI for Supplemental Screening in Patients With Dense Breasts: Comparison of Baseline Versus Subsequent-Round Examinations. AJR Am J Roentgenol. 2024. PMID: 38775433. doi:10.2214/AJR.24.31098

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。